Acquisition activity increasing of organizations with oncology-focused digital tools
BrightInsight’s platform is designed for pharmaceutical and medtech companies that want their devices and drug-delivery systems to talk to each other and generate usable information
New digital technologies offer a different approach to capturing, analyzing and predicting patient behavior.
etectRx and Proteus Digital Health are the only two companies offering Bioingestible sensors
Investment in Digital Therapeutics is expanding rapidly with industry stakeholders working to develop their strategies for success
PDTs are being developed for a range of conditions, from schizophrenia and depression, to multiple sclerosis and Alzheimer’s, to oncology and GI disorders, and more
Ironwood Pharmaceuticals testing digital therapeutics opportunity with Pear Therapeutics
Catalyze faster development of treatments for the autoimmune pancreatic disease